PAID CLINICAL TRIAL

• Lasting 17 months

• 15 Clinic Visits

YOU MAY BE ELIGIBLE TO PARTICIPATE IF YOU MEET THE FOLLOWING CRITERIA:​

• Have a diagnosis of Severe Hypertriglyceridemia (SHTG)

• Are 18 years of age and older

 

Hypertriglyceridemia is a common condition characterized by high levels of triglycerides, a type of fat, in the bloodstream. Individuals with severe hypertriglyceridemia (SHTG) have triglyceride levels more than three times the normal level. SHTG can lead to multiple serious conditions, including cardiovascular disease (CVD) and acute pancreatitis.

​

PURPOSE OF STUDY:

The purpose of this study is demonstrate the efficacy of plozasiran on reducing fasting serum TG levels.

​

​

​

​